Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Omega-3,Omega 6
Therapeutic Area : Dermatology
Study Phase : Approved
Sponsor : Nuvothera
Deal Size : Undisclosed
Deal Type : Licensing Agreement
DS Biopharma and Nuvothera Enter Option and License Agreement for EPADILIN®
Details : Under the terms of the agreement Nuvothera has acquired an option to exclusively licence rights to develop and commercialise EPADILIN® in the United States.
Brand Name : Epadilin
Molecule Type : Large molecule
Upfront Cash : Undisclosed
March 18, 2021
Lead Product(s) : Omega-3,Omega 6
Therapeutic Area : Dermatology
Highest Development Status : Approved
Sponsor : Nuvothera
Deal Size : Undisclosed
Deal Type : Licensing Agreement
LOOKING FOR A SUPPLIER?